Effect of Aerobic Exercise in Patients With Essential Hypertension
Effects of Supervised Versus Unsupervised Aerobic Exercise Training on Weight Loss, Functional Capacity, Quality of Life and Depression Level in Patients With Essential Hypertension
1 other identifier
observational
138
1 country
1
Brief Summary
The goal of this observational study is to evaluate the effects of a supervised aerobic exercise training program on weight loss, functional capacity, quality of life (QoL), and depression levels in patients with essential hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 25, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedAugust 14, 2023
August 1, 2023
1.4 years
July 25, 2023
August 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Body weight
kilograms
was measured at the pre-treatment period and the post-treatment 6th week for all the participants by the same physician.
Blood samples
Serum total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol, and triglycerides
Twelve-hour fasting blood samples were collected between 6.00 am, and 10.00 am at baseline and week 6.
The functional capacity
The 6MWT test and the estimated metabolic equivalents or METs were used performed to evaluate functional capacity.
6MWT was assessed in face-to-face interviews before and immediately after the treatment was completed.
Quality of Life
Quality of life was assessed with Short Form-36 (SF-36).
SF36 was assessed in face-to-face interviews before and immediately after the treatment was completed.
Depression level
Depression level was assessed Beck Depression Inventory (BDI).
BDI was assessed in face-to-face interviews before and immediately after the treatment was completed.
Study Arms (2)
Group 1
Group 1 exercised for six weeks, involving once per day, five sessions per week under the supervision of a medical doctor, and a nurse in the aerobic exercise laboratory. The aerobic exercise training program lasted six weeks, and patients lived in the hospital for the whole period. Aerobic exercise training was performed on cycle ergometers (Ergoline, ergoselect II 100/200/Reha, Germany) equipped with a computed ergometer and developed to monitor electrocardiography (ECG), heart rhythm, and BP. Each session consisted of a 5-minute warm-up, followed by 50 minutes of aerobic exercise with an intensity of 50% to 70% of heart rate reserve, calculated by Karvonen formula, and ended with a 5-min cool-down period.
Group 2
The subjects assigned to the control group (Group 2) were advised to maintain dietary habits and physical activity levels and the aerobic exercise program was provided to them after completing the study.
Interventions
Group 1 exercised for six weeks, five sessions per week under the supervision of a medical doctor in the aerobic exercise laboratory.
Eligibility Criteria
Patients with Essential Hypertension
You may qualify if:
- Over 18 years of age,
- Absence of concomitant other metabolic and cardiovascular diseases.
You may not qualify if:
- Having suffered an event of ischaemic heart disease (\<6 months),
- Secondary hypertension,
- Hypertrophic obstructive cardiomyopathy,
- Congestive heart failure,
- Uncontrolled cardiac arrhythmia,
- Thyroid dysfunction,
- Diabetes mellitus,
- Symptomatic peripheral arterial occlusive disease,
- Aortic insufficiency or stenosis,
- Pulmonary or heart disease with dyspnoea at small or moderate effort,
- An outbreak of orthopedic problems on hip, knee or ankles, such as arthroplasty, contracture or severe osteoarthritis,
- Using of antidepressant or anxiolytic drugs,
- Pregnancy,
- Cognitive disfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Selcuk University Faculty of Medicine
Konya, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
July 25, 2023
First Posted
August 14, 2023
Study Start
November 1, 2017
Primary Completion
April 1, 2019
Study Completion
December 1, 2019
Last Updated
August 14, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share